The emerging therapy of this peptide represents a exciting advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent https://tirzepatidepeptide949157.loginblogin.com/50222513/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment